Acute Pancreatitis Market | Therapeutics, Size, Growth

The new report published by The Business Research Company, titled ""Acute Pancreatitis Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=10796&type=smp

Surging Alcohol Consumption Fuels Growth In The Acute Pancreatitis Market
The increasing prevalence of alcohol consumption is expected to propel the growth of the acute pancreatitis market going forward. Alcohol consumption refers to consuming an ethanol-containing beverage, usually orally. Chronic inflammation and toxic fluid production in the pancreas can both be brought on by alcohol intake. The prevalence of alcohol consumption increases in a population, potentially leading to a higher incidence of acute pancreatitis cases. For instance, in January 2022, according to Rabobank, a Netherland-based multinational banking and financial services company, online alcohol sales from grocery shops more than doubled from an estimated $441 million in 2019 to $1.6 billion in 2021. Further, sales increased by around 15% in 2022 to reach $1.87 billion. Therefore, the increasing prevalence of alcohol consumption is driving the growth of the acute pancreatitis market.

Acute Pancreatitis Market Embraces Technological Advancements In Diagnosis And Treatment
Technological advancements in diagnosis and treatment are a key trend gaining popularity in the acute pancreatitis market. Major companies operating in the acute pancreatitis market are adopting new technologies such as computed tomography (CT) scans, magnetic resonance imaging (MRI), endoscopic ultrasound (EUS), Endoscopic Retrograde Cholangiopancreatography (ERCP), and interventional radiology to sustain their position in the market. For instance, in September 2021, Samsung Medison Co., Ltd., a South Korea-based manufacturing company of diagnostic ultrasound machines, launched the V8, a high-end ultrasound device that offers improved picture quality, ease of use, and convenience to medical practitioners of all stripes. The ""V"" in V8 refers to ""Versatile,"" indicating that the sophisticated features of high-end ultrasound systems intended for certain specialties like radiology, orthopedics, cardiology, and obstetrics have been integrated. Among the many diagnostic aid capabilities of an outstanding ultrasound system for radiology, V8 includes S-Shearwave Imaging, which uses ultrasonic transverse elasticity to offer information on tissue stiffness as a result of illness. S-Fusion, another feature of V8, enables the simultaneous alignment of ultrasonic medical pictures with one or more cross-sectional investigations, including MRIs, which are then quickly rebuilt in the appropriate plane.

The acute pancreatitis market covered in this report is segmented -

1) By Cause: Gallstones, Alcohol, Other Causes
2) By Treatment: Intravenous Fluid, Nutritional Support, Analgesics, Endoscopic Retrograde Cholangiopancreatography (ERCP), Other treatments
3) By Diagnosis: Imaging tests, Laboratory Tests
4) By End Users: Hospitals, Clinics, Other End-Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=10796&type=discount

Major companies operating in the acute pancreatitis market report are CalciMedica Inc., SCM Lifescience Co. Ltd., Samsung Bioepis Co Ltd., Global Neurotech Pharma Corporation, Baxter International Inc., B. Braun Melsungen AG, General Electric Company, Medtronic plc, Boston Scientific Corporation, Fresenius Kabi AG, McNeil Consumer Healthcare, Sun BioPharma Inc., Atox Bio Inc., D-Pharm Ltd., Regeneron Pharmaceuticals Inc., Merck & Co Inc, Olympus Corporation, Pfizer Inc., Ionis Pharmaceuticals Inc., Abbott Laboratories, Dynavax Technologies Corporation, GlaxoSmithKline plc, AbbVie Inc., Allergan plc, Amgen Inc., AstraZeneca PLC, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Novartis AG, Sanofi SA, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Vertex Pharmaceuticals Incorporated, Johnson & Johnson,

Contents of the report:
1. Executive Summary
2. Acute Pancreatitis Market Report Structure
3. Acute Pancreatitis Market Trends And Strategies
4. Acute Pancreatitis Market - Macro Economic Scenario
5. Acute Pancreatitis Market Size And Growth
…..
27. Acute Pancreatitis Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/acute-pancreatitis-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.